Arthur Aung (@Arthur_Aung) profile picture

Arthur Aung

@Arthur_Aung

Hematology Oncology Fellow | Northwell Health Northshore/LIJ Hospital

 New York, USA
Joined July 2012
  • Tweets132
  • Following1.4K
  • Followers248
15Media
Photo by Arthur Aung (@Arthur_Aung)Photo by Arthur Aung (@Arthur_Aung)Photo by Arthur Aung (@Arthur_Aung)Photo by Arthur Aung (@Arthur_Aung)Photo by Arthur Aung (@Arthur_Aung)Photo by Arthur Aung (@Arthur_Aung)Photo by Arthur Aung (@Arthur_Aung)Photo by Arthur Aung (@Arthur_Aung)Photo by Arthur Aung (@Arthur_Aung)
Arthur Aung retweeted
Jafar Najafov (@JafarNajafov) profile picture
Jafar Najafov
@JafarNajafovJun 6
Claude can now break down papers like an MIT researcher. Here are 10 insane Claude prompts that turn dense research papers into simple summaries, diagrams, limitations, experiments, and future research ideas in minutes (Save this)
Image from Jafar Najafov (@JafarNajafov)
9
49
1
160
23,353
Congrats to @NehemiasGuevar5 & team #ASCO26 Key takeaways for oncologists: 🔹 Autoimmune disease ≠ automatic exclusion from ICIs 🤔 Requires careful toxicity monitoring & patient selection 🤝 Strong oncology + rheumatology collaboration is critical 🔹 Shared decision-making remains essential Important real-world data for everyday practice 💉🫁 #Immunotherapy @ASCOTECAG @hemeoncfellow @HemOncFellows @ASCO
FlorezLab (@Florez_Lab) profile pictureFlorezLab
@Florez_LabJun 1
Join @NehemiasGuevar5 at #ASCO26 as he presents Poster 81: “Survival outcomes in individuals with cancer and pre-existing autoimmune disease receiving immune checkpoint inhibitors 📍 Hall A 🗓 June 1 ⏰ 9:00 AM–12:00 PM
Image from FlorezLab (@Florez_Lab)
2
1
5
1,127
What environmental factors may contribute to lung cancer risk beyond smoking? Looking forward to presenting our #ASCO26 poster on ambient carbon tetrachloride exposure and lung cancer incidence in the U.S. Abstract: asco.org/abstracts-presentat… @NagashreeSeeth1 @NorthwellHealth
1
2
4
243
Now focusing on the rapid oral abstract head and neck cancers (Monday 6/1 at 4:30 PM CT)- a fascinating line up featuring novel therapeutics and strategies-hinting towards a brighter future
Image from Nagashree Seetharamu, MD, FASCO (@NagashreeSeeth1)
1
8
533
Arthur Aung retweeted
Liang Chang (@liangc_science) profile picture
Liang Chang
@liangc_scienceApr 10
I used a team of ~30 AI agents to analyze 57,603 ASCO Abstracts between 2016-2025. Here are my top 6 learnings on the past decade of oncology open.substack.com/pub/liangc…
Image from Liang Chang (@liangc_science)
1
7
2
29
21,229
Excited to share our new publication with @NarjustFlorezMD @MImbimbo1 @COlazagasti on lung cancer diagnosed during pregnancy — a rare and highly complex clinical scenario requiring multidisciplinary care. frontiersin.org/journals/onc…
Frontiers | Treating without guidelines: management and outcomes of lung cancer diagnosed during...

Frontiers | Treating without guidelines: management and outcomes of lung cancer diagnosed during...

BackgroundLung cancer during pregnancy is exceedingly rare and poses unique diagnostic and therapeutic challenges. Clinical decisions must balance urgent, po...

frontiersin.org
1
6
1
16
2,584
Conference season is upon us with poster sessions, #oralabstracts, and #grandrounds on the horizon! To help prepare, we wrote this #ASCOconnection article: 🔗 The High-Stakes Talk 🗣️ @jennifermarksmd @ASCO In the piece, we share practical strategies to: 🔹 Lead with the core message 🔹 Make the “so what” clear 🔹 And more Because strong science should be easy to understand, discuss, remember, and carry forward. 🙋🏾‍♂️What is the best presentation advice you have received or the one lesson you wish you had learned earlier? connection.asco.org/do/high-… #Oncology #MedEd #ASCOtips #PresentationTips #PosterPresentation #ResearchTalks @hemeoncfellow @HemOncFellows @SNMA @LmsaNational @ASCOTECAG @OncoAlert @oncodaily
The High-Stakes Talk: Making Your Science Clear, Compelling, and Memorable at Major Meetings

The High-Stakes Talk: Making Your Science Clear, Compelling, and Memorable at Major Meetings

“How you present your findings shapes how they are understood, remembered, and applied. In a field where evidence evolves quickly and stakes are measured in lives, clarity is a skill and a responsibil

connection.asco.org
1
9
3
19
2,733
#TumorBoardTuesday 🫁 Early-stage #NSCLC is no longer just surgery ➕ chemo: Molecular testing now shapes curative-intent Tx decisions 🧬 📢Join us Tuesday, 05-05-26 at 8PM ET as @NarjustFlorezMD & @NehemiasGuevar5 🗣️EGFR+ Early #NSCLC RT and bring others into the discussion‼️
Image from #TumorBoardTuesday (@TumorBoardTues)
13
10
2
26
3,461
Join us tomorrow at 8 PM ET for a deep dive into early-stage #NSCLC and #NeoADAURA @TumorBoardTues @NarjustFlorezMD @Florez_Lab @OncBrothers @COlazagasti @dominicandoc2 @oncodaily @Arthur_Aung @guicorreiamd @IMG_Oncologists @Shuai_WangOnc @HyeinJeon_MD @TejaVorugantiMD @OncLive
#TumorBoardTuesday (@TumorBoardTues) profile picture#TumorBoardTuesday
@TumorBoardTuesMay 4
#TumorBoardTuesday 🫁 Early-stage #NSCLC is no longer just surgery ➕ chemo: Molecular testing now shapes curative-intent Tx decisions 🧬 📢Join us Tuesday, 05-05-26 at 8PM ET as @NarjustFlorezMD & @NehemiasGuevar5 🗣️EGFR+ Early #NSCLC RT and bring others into the discussion‼️
Image from #TumorBoardTuesday (@TumorBoardTues)
8
1
16
1,130
Replying to @TLCconference
@TLCconference more than a conference! Networking with a great group of colleagues at the faculty dinner! Sharing experiences and points of view! 🤯 Blessed to be here in such a great community! @StephenVLiu #TinaCascone @rolfolab
Image from Roberto Borea, MD (@RobertoBoreaMD)
6
20
1,012
Arthur Aung retweeted
TLC Conference (@TLCconference) profile picture
TLC Conference
@TLCconferenceApr 9
Here we go 🤩 The 4th annual Texas Lung Cancer Conference kicks off tonight at 6 pm with the Welcome Reception & Poster Presentation at @acllive. We're thrilled to highlight the winning abstracts and welcome our faculty and attendees for an evening of networking. Don't forget to grab your badge at the registration desk first. See you soon! Congratulations to @JackieAredoMD, Zhaohui Arter, @yajur_arya, Wint Aung, @RobertoBoreaMD, @KCargillMDPhD, @DivyaReddyMD, @GraceHaMD, Pragya Jain, John Nawrocki, Max Schuessler, Xin Sun, Lauryn Tu, and Alessandra Vaccaro. ow.ly/V8TL50YFhiE
Image from TLC Conference (@TLCconference)
3
11
1
26
3,849
A VERY applicable case presented by THE AMAZING @NagashreeSeeth1 of discovering Met amp. A reminder to 👀 for MET and HER IHC on all our patients. We have approvals for these with TELISO-V and TDX-D #NYL25 @gotoPER @NorthwellHealth
Image from Isabel Preeshagul (@ipreeshagul)
2
2
10
810
💡Starting out in thoracic oncology? The @IASLC Communications Committee proudly brings you: ‘50 Years of Progress in NSCLC: A New Fellow’s Guide in the Clinic’ A whistlestop tour of key advances, distilled by global leaders @JTOonline @OncoAlert #LCSM jto.org/article/S1556-0864%2…
50 Years of Progress in NSCLC: A New Fellow’s Guide in the Clinic

50 Years of Progress in NSCLC: A New Fellow’s Guide in the Clinic

In the past 50 years, we have seen a dramatic evolution in thoracic oncology. We have gone from a time of limited understanding of the biology of lung cancer, no demonstrated benefits for screening,...

jto.org
7
35
4
111
24,096
Breaking in #LungCancer: FDA has approved taletrectinib (Ibtrozi) for adults with ROS1-positive NSCLC (locally advanced or metastatic) as of June 11 2025 A new targeted option joins the fight 📌 Developed by Nuvation Bio @ASCO @Arthur_Aung @HemOncFellows @dominicandoc2 @oncodaily
Image from Nehemias Guevara-Rodriguez (@NehemiasGuevar5)
1
9
363
Woohoo! So nice to see focus back on Head and neck cancer after a long time! Just about time #ascoplenary #NIVOPOSTOP @ASCO #ASCO2025 significant DFS benefit. #hnscc
1
5
804
Proud to be an investigator in the head and neck cohort of SGN35-033. Our data was discussed today at @ASCO, showing promising clinical efficacy of BV + Pembro in treatment -naive patients with metastatic HNSCC and CPS ≥1. meetings.asco.org/abstracts-… @NebraskaMed @UNMCHemeOnc
Image from Omar Abu Ghanimeh (@omarabughanimeh)
1
2
1
11
989
Dr. Pasi Janne at #ASCO25 with update on KRYSTAL7: phase II study of first line adagrasib plus pembrolizumab for #KRAS G12C NSCLC. RR 44% (61% for PDL1 high). mDOR 26.3m, PFS 11m (27.7m for PDL1 high), OS 18.3m. 17% had to stop pembro for TRAE.
Image from Stephen V Liu, MD (@StephenVLiu)
Image from Stephen V Liu, MD (@StephenVLiu)
Image from Stephen V Liu, MD (@StephenVLiu)
Image from Stephen V Liu, MD (@StephenVLiu)
23
56
3,980
The #NextWaveForum is a meaningful longitudinal connection with peers and mentors, helping shape our future as medical/thoracic oncologists. Grateful for the opportunity to catch up with everyone yesterday! @SWaliany @BenBleibergMD @anuja_abhyankar @LealTiciana @Arthur_Aung @dominicandoc2
Image from Chinmay Jani (@Jani_Chinmay)
Image from Chinmay Jani (@Jani_Chinmay)
Image from Chinmay Jani (@Jani_Chinmay)
2
14
434
Excited to join the @cancerGRACE team as an ambassador alongside @Arthur_Aung and @your_hemoncdoc! Looking forward to contributing to #patient #education and empowering through knowledge.
Image from Chinmay Jani (@Jani_Chinmay)
1
5
2
16
3,878
🎬 Behind the scenes at the @OncBrothers x @SignifyMD shoot with @Jani_Chinmay and @COLazagasti—filming this was a blast! 🔊 Sharp clinical insights, effortless chemistry, and plenty of laughs between takes. They dive into real-world #EGFR sequencing strategies and the evolving role of #tarlatamab even outside academic centers. A must-watch for anyone navigating biomarker-driven care in lung cancer. 🧬💡 Stay tuned—the full convo drops soon, and you won’t want to miss it. 🎤📹🔥 @SylvesterCancer @HemOncMiami #LCSM #OncTwitter #MedEd
Image from Abner Antonio Murray, MD PhD (@dominicandoc2)
Image from Abner Antonio Murray, MD PhD (@dominicandoc2)
Image from Abner Antonio Murray, MD PhD (@dominicandoc2)
6
1
10
3,405
Load more